Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome （IBS)
Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study are as follows: 1) To evaluate the efficacy and safety of Qizhi
Weitong granules in the treatment of diarrhea-type irritable bowel syndrome (IBS-D);2) To
explore the dosage of Qizhi Weitong Granulesin treatment of IBS-D.
Phase:
Phase 2
Details
Lead Sponsor:
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.